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Ginseng, the root of Panax ginseng C.A. Meyer, is one of the oldest traditional medicines
and is thought to be a tonic. It has been claimed that ginseng may improve vitality and
health. Recent studies have advanced ginseng pharmacology and shown that ginseng has
various pharmacological effects in the nervous system. Ginsenosides, steroid glycosides
extracted from ginseng, were one of the first class of biologically active plant glycosides
identified. The diverse pharmacological effects of ginsenosides have been investigated
through the regulation of various types of ion channels and receptors in neuronal cells and
heterologous expression systems. Ginsenoside Rg3 regulates voltage-gated ion channels
such as Ca2+, K+, and Na+ channels, and ligand-gated ion channels such as GABAA, 5-HT3,
nicotinic acetylcholine, and N-methyl-D-aspartate (NMDA) receptors through interactions
with various sites including channel blocker binding sites, toxin-binding sites, channel
gating regions, and allosteric channel regulator binding sites when the respective ion
channels or receptors are stimulated with depolarization or ligand treatment. Treatment
with ginsenoside Rg3 has been found to stabilize excitable cells by blocking influxes
of cations such as Ca2+ and Na+, or by enhancing Cl− influx. The aim of this review
is to present recent findings on the pharmacological functions of the ginsenosides
through the interactions with ion channels and receptors. This review will detail the
pharmacological applications of ginsenosides as neuroprotective drugs that target ion
channels and ligand-gated ion channels.
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INTRODUCTION
Ginseng, the root of Panax ginseng C.A. Meyer, contains a variety
of ingredients useful in herbal medicines (Tyler, 1995). Ginseng
glycosides, also called ginsenosides or ginseng saponin, are deriva-
tives of triterpenoid dammarane, which consists of 30 carbon
atoms. Each ginsenoside has a common hydrophobic four ring
steroid-like structure with carbohydrate moieties attached (Nah
et al., 2007). Several types of ginsenosides have been isolated and
identified from the roots of various ginseng species fromAmerica,
China, and Korea. They are mainly classified as protopanaxa-
diol (PD), protopanaxatriol (PT), oleanolic ginsenosides, and
ginsenoside metabolites according to the position of different car-
bohydrate moieties at the carbon-3 and carbon-6 positions, as
well as the aliphatic side chain (Figure 1). Recent studies have
demonstrated that ginsenosides exhibit a variety of pharmaco-
logical effects in nervous and non-nervous systems. A line of
accumulating evidence shows that ginsenoside Rg3, the most
active ginsenoside, interacts and regulates voltage-gated ion chan-
nels and ligand-gated ion channel activity through interaction
with specific amino acid(s) at channel entryways or channel pore
regions that are associated with ion influx or efflux (Lee et al.,
2004b). This review will describe the physiology and pharmacol-
ogy of ginseng ginsenoside in the regulation of voltage-gated ion
and ligand-gated ion channel activities through interactions with
specific amino acids of channel proteins and receptors.
GINSENOSIDE PHARMACOLOGY THROUGH THE
INTERACTIONWITH VOLTAGE-GATED ION CHANNELS
REGULATION OF VOLTAGE-GATED Ca2+ CHANNELS BY GINSENOSIDES
Ginseng extract and ginsenosides inhibit Ca2+ channel currents
in sensory neurons. Among the various ginsenosides such as
Rb1, Rc, Re, Rf, and Rg1, ginsenoside Rf was found to be the
most effective in inhibiting Ca2+ channel activities (Nah et al.,
1995). Ginsenosides also inhibit Ca2+ channels in rat chromaf-
fin cells, which are one of the representative neurosecretory cells
involved in catecholamine release under various stress conditions
(Kim et al., 1998a). The ginsenosides listed in order of inhibitory
potency on Ca2+ channels in rat chromaffin cells are: ginsenoside
Rc > Re > Rf > Rg1 > Rb1. Ginsenosides showed a selec-
tivity in Ca2+ channel regulation, inhibiting N-, P-, and Q/R-,
but not L-type Ca2+ channels in bovine chromaffin cells (Choi
et al., 2001). Ginsenoside Rg3 more potently inhibits L-, N-, and
P-type Ca2+ channels than other ginsenosides tested in rat sen-
sory neurons (Rhim et al., 2002). Ginsenoside Rb1 selectively
inhibits L-type Ca2+ channel activity in cultured rat hippocampal
neurons (Lin et al., 2012). Besides neuronal Ca2+ channels, gin-
senoside Re also selectively inhibits L-type Ca2+ channel activity
in guinea pig cardiomyocytes (Bai et al., 2003, 2004). In addition,
ginsenosides attenuated the stimulation of membrane capaci-
tance increase (Cm) in rat chromaffin cells. The ginsenosides
listed in order of inhibitory potency on Cm are: ginsenoside Rf
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FIGURE 1 | Structures and main metabolic pathways of
20(S)-ginsenoside Rb1, 20(S)- ginsenoside Rg1, and 20(S)-
ginsenoside Rg3. Ginsenosides are known to be metabolized by
human intestinal microflora. This scheme represents the structures
and proposed metabolic pathways of 20(S)-ginsenoside Rb1,
20(S)-ginsenoside Rg1, and 20(S)-ginsenoside Rg3. Bold arrow: main
pathway. Dotted arrow: minor or weak pathway. Adapted from Nah
et al. (2007).
> Rc > Re > Rg1 > Rb1 (Kim et al., 1998a). The regulation of
Ca2+ channel activity andmembrane capacitance by ginsenosides
indicates that ginsenosides are closely involved in the regulation
of neurotransmitter release from presynaptic nerve terminal(s)
(Duan and Nicholson, 2008).
IDENTIFICATION OF GINSENOSIDE INTERACTION SITES IN
VOLTAGE-GATED Ca2+ CHANNEL REGULATION
Among the various domains of the L-type Ca2+ channel pro-
tein, mutations in L427R, N428R, and L431K in transmembrane
domain-I-segment 6 (IS6) of the channel significantly attenu-
ated the action of ginsenoside Rg3, resulting in a shift to the
right in dose-response curves, although the inhibitory effects of
ginsenoside Rg3 on Ca2+ channel currents was not completely
abolished (Choi et al., 2009). In addition, while ginsenoside Rg3
treatment produced a negative shift in the inactivation voltage,
it did not alter the steady-state activation voltage, and none
of the mutant channels affected the ginsenoside Rg3-induced
negative shift in inactivation voltage. Ginsenoside Rg3 had no
effect on the inactivation time constant in wild-type and mutant
channels. Thus, mutations in L427R, N428R, and L431K in trans-
membrane domain-I-segment 6 (IS6) of the channel partially
attenuated ginsenoside Rg3 action. The Leu427, Asn428, and
Leu431 residues of the transmembrane domain-I-segment 6 of
L-type Ca2+ channels play important roles in the regulation of
L-type Ca2+ channels by ginsenoside Rg3 (Choi et al., 2009)
(Figure 2).
REGULATION OF VOLTAGE-GATED K+ CHANNELS BY GINSENOSIDES
Ginseng total saponins and ginsenoside Rg3 have been shown
to activate Ca2+-activated K+ and ATP-sensitive K+ channels
in rabbit coronary artery smooth muscle cells (Chung and
Kim, 1999; Chung and Lee, 1999). Ginsenosides activate Ca2+-
activated K+ channels in vascular smooth muscle cells (Li et al.,
2001). In addition, the external application of ginseng total
saponin fraction and ginsenoside Rg3 to rabbit coronary artery
smooth muscle cells has been shown to increase the amplitude
of whole-cell BKCa currents (Chung and Kim, 1999). Treatment
with ginseng total extract relaxed rabbit vaginal tissue via hyper-
polarization of BKCa channel activation (Kim et al., 2008a). In
guinea pig cardiomyocytes, ginsenoside Re enhanced the delayed
rectifier K+ channel (IKs) (Bai et al., 2003, 2004). Ginsenoside-
induced relaxation of blood vessels and other smooth muscles
may be achieved via activation of K+ channels (Kim et al.,
1999).
By contrast, ginsenoside Rg3 inhibits voltage-dependent Kv1.4
and Kv4.2 in human cells, but not Kv1.3, Kv1.5, and Kv2.1
expressed in Xenopus laevis oocytes (Jeong et al., 2004; Lee
et al., 2013c), indicating that ginsenoside Rg3 differentially reg-
ulates Kv channel subtypes. The regulatory effect of ginsenoside
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Rg3 on Kv1.4 channel activity has been found to be strongly
dependent on the extracellular K+ concentration, by shift-
ing the ginsenoside Rg3 concentration-response curve to the
right, indicating that ginsenoside Rg3 competes with extracel-
lular [K+] for the same interaction site(s) (Lee et al., 2008a).
Further study showed that the inhibitory effects of ginsenoside
Rg3 on Kv1.4 channel currents were abolished by K+ activa-
tion, which is induced by increasing extracellular K+ concen-
trations. In addition, some subsets of Kv channel currents are
also affected by extracellular and intracellular tetraethylammo-
nium (TEA), which is a well-known K+ channel blocker. The
wild-type Kv1.4 channel, however, is nearly insensitive to TEA
(Pardo et al., 1992; Lee et al., 2008a). Thus, although extra-
cellular TEA treatment did not inhibit the wild-type Kv1.4
channel, it appeared that extracellular TEA competed with gin-
senoside Rg3 to inhibit Kv1.4 channel currents by shifting
the ginsenoside Rg3 concentration-response curve to the right
(Lee et al., 2008a). Based on these results, ginsenoside Rg3
may have specific interaction site(s) for Kv1.4 channel activity
regulation.
GINSENOSIDE Rg3 INTERACTS WITH THE EXTRACELLULAR TEA
BINDING SITE TO REGULATE Kv1.4 CHANNEL ACTIVITY
The K+ activation site of the Kv1.4 channel, which is located
at the outer pore entry, consists of several amino acids includ-
ing lysine 531 (K531) (Claydon et al., 2004). In addition, one
of the extracellular TEA binding sites also contains the K531
residue. Mutations in this K531 residue to tyrosine (i.e., K531Y)
increased the sensitivity of the Kv1.4 channel to extracellular
TEA, abolished K+ activation, and also abolished the effect of
ginsenoside Rg3 on the Kv1.4 channel. Thus, ginsenoside Rg3-
mediated action of Kv1.4 channel activity may occur through
common interaction site(s) for K+ activation and TEA bind-
ing sites. Alternatively, the ginsenoside Rg3 interaction site(s)
may overlap or share the K+ activation site or the TEA binding
FIGURE 2 | Topology and sequence alignment of Cav1.2, Nav1.2, and
Nav1.4 channels. Ca2+ and Na+ channels consist of the main α subunit
and other auxiliary subunits. α subunit has 4 domains and each domains
contain 6 segments. Each segment 4 plays a membrane voltage sensor
and segments 5 and 6 form channel pore. The mutated amino acid residues
are underlined in the pore-forming segment 6. The underlined specific
amino acid residues in these channels are thought to interact with
20(S)-ginsenoside Rg3 (Rg3) (Lee et al., 2008b; Choi et al., 2009).
site, as shown by Lee et al. (2008a) using various Kv1.4 chan-
nel mutations, including the K531 residue. Mutations have been
generated in channel pore sites (S510K, D513Q, V525L, and
V535Q) and outer pore sites (K531A, P532A, I533A, T534A,
and V535A) (Watanabe et al., 2004). Kv1.4 channel mutations
have also been generated in the N-glycosylation site (N353Q)
(Judge et al., 1999), the voltage sensor site (R447C and R450C)
(Claydon et al., 2004), the voltage shift sites (L478F and G548P)
(Bett and Rasmusson, 2004), the pH sensitive site (H507Q),
and the C-type inactivation site (V560A) (Claydon et al., 2004).
The K531A mutant, located in one of the outer pores, signif-
icantly attenuated ginsenoside Rg3 inhibition of Kv1.4 channel
currents, while the other mutations had no significant effect.
Thus, ginsenoside Rg3 regulates Kv1.4 channel activity by inter-
acting with Lys531, which is also known to be one of the K+
activation sites and one of the extracellular TEA binding sites.
Other mutant channels at the K531 residue, such as K531Y,
I533M, and K531Y-I533M, showed that the K531Y substitution,
but not I533M, and the K531Y-I533M double substitution mostly
abolished ginsenoside Rg3 inhibition of Kv1.4 channel currents
(Lee et al., 2008a). Ginsenoside Rg3-mediated action of Kv1.4
channel activity is closely associated with the Lys531 residue
(Figure 3).
Using homology and virtual docking model methods, which
give three-dimensional configurations, Lee et al. (2008a) demon-
strated that ginsenoside Rg3 could bind to the Kv1.4 channel
protein through various interactions such as hydrogen bonds or
hydrophobic interactions. Therefore, the carbohydrate portion of
ginsenoside Rg3 plays an important role in its interaction with
the Kv1.4 channel. The second, but not the first, carbohydrate
attached at carbon-3 of the ginsenoside Rg3 backbone forms six
FIGURE 3 | Topology and sequence alignment of BKCa, hERG, KCNQ1,
and Kv1.4 K+ channels. BKCa, hERG, KCNQ1, and Kv1.4 K+ consist of the
main α subunit and auxiliary β subunits. Tetramer of α subunit forms a
functional K+ channel. α subunit contains 6 segments. Each segment 4
plays a membrane voltage sensor and segments 5 and 6 form channel
pore. The mutated amino acid residues are underlined in the pore-forming
segment 5 and 6. The underlined specific amino acid residues in those K+
channels are thought to interact with 20(S)-ginsenoside Rg3 near the K+
channel “signature sequence” of –TXGYGD– (Lee et al., 2008a; Choi et al.,
2010, 2011a,b).
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hydrogen bonds with amino acids in the pore entryway of the
Kv1.4 channel. Among the amino acids forming hydrogen bonds
with ginsenoside Rg3, K531 forms three bonds, and threonine and
histidine form the other hydrogen bonds. In addition, the gin-
senoside Rg3 backbone is located in the pore portion of the Kv1.4
channel, enabling it to block the pore and interrupt K+ efflux
when the channel is stimulated by depolarization. The backbone
of ginsenoside Rg3 may act as a physical plug or wedge in ginseno-
side Rg3-mediated Kv1.4 channel regulation. However, the K531Y
mutant in the Kv1.4 channel forms only two hydrogen bonds with
ginsenoside Rg3. Thus, the use of site-directed mutagenesis, as
well as homology and virtual docking model methods, are use-
ful tools to confirm and identify ginsenoside Rg3 interaction sites
on the Kv1.4 channel (Figure 3).
GINSENOSIDE Rg3 REGULATES BKCa CHANNEL ACTIVITY THROUGH
INTERACTION WITH AMINO ACID RESIDUES HOMOLOGOUS TO THE
Kv1.4 CHANNEL
Ginsenoside Rg3 enhanced BKCa channel currents, in contrast to
its inhibitory effect on Kv1.4 channel currents (Choi et al., 2011a).
Interestingly, BAPTA, a Ca2+ chelator, did not block ginsenoside
Rg3-induced enhancement of BKCa channel currents, indicating
that ginsenoside Rg3-enhancement of BKCa channel currents was
independent of intracellular Ca2+. The BKCa channel was sensi-
tive to TEA, with a significant shift in the concentration response
curve of ginsenoside Rg3 to the right in the presence of TEA, and
vice versa in the wild-type channel, indicating that ginsenoside
Rg3 competes for extracellular TEA binding site(s), similarly to
mutant Kv1.4 channel interaction (Lee et al., 2008a). In addi-
tion, Choi et al. (2011a) reported that ginsenoside Rg3-induced
enhancement of the BKCa channel current was independent of the
β subunit, suggesting that ginsenoside directly interacts with the
BKCa channel α subunit. At the channel pore entry of the α sub-
unit in mutant BKCa channels, the effect of ginsenoside Rg3 on
BKCa channel current enhancements was also almost abolished,
for instance, in Y360I mutant channels, in which the residue is
located at near K+ channel signature sequence, which is also
known as the extracellular TEA binding site of the BKCa channel
(Choi et al., 2011a) (Figure 3).
GINSENOSIDE Rg3 ALSO REGULATES hERG K+ (IKr ) AND KCNQ K+
CHANNEL (IKs) ACTIVITY THROUGH INTERACTION WITH AMINO ACID
RESIDUES HOMOLOGOUS TO THE Kv1.4 CHANNEL
Ginsenosides have been shown to exhibit anti-hypertension and
cardio-protective effects (Attele et al., 1999). Ginseng extract
shortens action potential duration, whereas ginsenoside Re has
been shown to regulate the IKr and IKs channel currents of guinea
pig cardiomyocytes (Bai et al., 2003; Furukawa et al., 2006).
However, relatively little is known at the molecular level about
how ginseng extract and ginsenosides shorten action potential
duration through the activation of hERG (IKr) and KCNQ (IKs)
K+ channels. Ginsenoside Rg3 has been shown to regulate hERG
(IKr) K+ channel by enhancing IhERG and Itail. Ginsenoside Rg3
not only caused a persistent Ideactivating−tail without decay but also
decelerated deactivating time constants. The mutation of S631
to S631C in the hERG α subunit has been reported to abolish
ginsenoside Rg3-mediated action of hERG K+ channels. Thus,
ginsenoside Rg3 enhanced IhERG and Itail, and induced a persistent
Ideactivating−tail with delayed deactivation of the hERG K+ channel
through interaction with the S631 residue (Choi et al., 2011b)
(Figure 3).
Ginsenoside Rg3 enhances IKs currents, indicating that it reg-
ulates the KCNQ (IKs) K+ channel, which consists of KCNQ1
and KCNE1 subunits (Choi et al., 2010). Site-directed mutagen-
esis has shown that the K318 and V319 residues of the KCNQ1
or KCNQ1 plus KCNE1 channels are involved in ginsenoside
Rg3-mediated action of KCNQ1 plus KCNE1 channel activ-
ity (Figure 3). Homology docking models show that the K318
residue plays an important role in the interaction of ginsenoside
Rg3 in the closed or open state of the channels (Choi et al., 2010).
Ginsenoside Rg3 interacts with the S631 residue of the hERG K+
channel and the K318 and V319 residues of the KCNQ1 plus
KCNE1 channel, respectively.
REGULATION OF VOLTAGE-GATED Na+ CHANNEL BY GINSENOSIDES
Ginsenosides also regulate Na+ channel activities, for instance,
inhibiting neuronal Na+ channels expressed in tsA201 cells
and Xenopus laevis oocytes. Higher concentrations of gin-
seng extract and ginsenoside Rb1 than those used in other
channel interaction experiments were required to inhibit Na+
channel currents (Liu et al., 2001). Ginsenoside Rg3 was
highly potent in inhibiting Na+ channel currents compared
to ginseng extract and the other ginsenosides tested (Jeong
et al., 2004). In structure-activity relationships of the ginseno-
side Rg3 stereoisomers, 20(S)-ginsenoside Rg3 but not 20(R)-
ginsenoside Rg3 inhibited the neuronal Na+ channel currents
in a dose- and voltage-dependent manner. The hydroxyl group
at carbon-20 of 20(S)-ginsenoside Rg3 may be geometrically
better aligned with the hydroxyl acceptor group in the ion
channels than that of the 20(R)-ginsenoside Rg3 (Jeong et al.,
2004).
A structure-activity relationship study of ginsenoside Rg3
investigated the role of the aliphatic side chain, [-CH2CH2CH =
C(CH3)2], which is coupled to carbon-20 of the 20(S)-
ginsenoside Rg3 backbone in Na+ channel interaction (Lee et al.,
2008c). The reduction of the double bond in the aliphatic side
chain of 20(S)-ginsenoside Rg3 strengthens the inhibitory effect
on Na+ channel activity, shifting the concentration-response
curve significantly to the left. However, deletion, hydroxylation,
or oxygenation of the aliphatic side chain caused an attenuation
or loss of Na+ channel current inhibition. The aliphatic side chain
of 20(S)-ginsenoside Rg3, as well as the hydroxyl group of carbon-
20 of ginsenoside Rg3 stereoisomers, plays an important role in
Na+ channel regulation. Thus, the aliphatic side chain of ginseno-
side Rg3 may be a future target for chemical modifications to tune
regulation of Na+ channels by Rg3.
In further studies on ginsenoside Rg3-mediated voltage-gated
neuronal Na+ channel interaction, two main characteristics have
been identified. One is that ginsenoside Rg3 treatment causes a
depolarizing shift in the activation voltage step in wild-type Na+
channels, indicating that ginsenoside Rg3 binding to the Na+
channel does not allow the Na+ channel to easily open at a given
voltage step, requiring greater depolarizing stimulation compared
to untreated channels (Lee et al., 2005). The other characteristic
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is that ginsenoside Rg3 induces use-dependent inhibition, mean-
ing that the channel pore-blocking actions of ginsenoside Rg3 are
enhanced by rapid, repeated stimulation over a very short time
period, indicating that ginsenoside Rg3 may be a kind of open
channel blocker.
The idea that ginsenoside Rg3 is a kind of open channel blocker
of Na+ channel is supported by experiments using inactivation-
deficient Na+ channel mutants, in which the inactivation gate
has been mutated from IFM to Q3, and transient inward cur-
rents are converted into long-lasting inward currents (Lee et al.,
2005). Ginsenoside Rg3 more potently inhibited the plateau than
peak INa, and facilitated channel closing in inactivation-deficient
channel mutants. Interestingly, mutations in one amino acid
(Lys859 to Glu859 in brain NaV1.2 channel) in the voltage-sensor
domain in the S4 helix abolished the ginsenoside Rg3-mediated
depolarizing shift without affecting the ginsenoside Rg3-mediated
inhibition of peak current (INa). These results indicate that gin-
senoside Rg3 may have interaction sites for the brain Nav1.2
channel regulation.
IDENTIFICATION OF GINSENOSIDE INTERACTION SITES IN
VOLTAGE-GATED Na+ CHANNEL REGULATION
Although ginsenoside Rg3 regulates neuronal Na+ channels as
a kind of open channel blocker, showing use-dependent inhibi-
tion and a depolarizing shift in the activation curve of wild-type
Na+ channels, the exact interaction sites in the Na+ chan-
nel proteins have not been identified. Batrachotoxin (BTX) is
a neurotoxin that acts on Na+ channels. BTX toxin was first
found in the skin of the South American frog Phyllobates terri-
bilis, and persistently activates brain NaV1.2 and skeletal muscle
NaV1.4 channels, rather than inhibiting Na+ currents as lido-
caine and tetrodotoxin do (Wang and Wang, 1998). In addition,
BTX is a steroidal alkaloid toxin, with a backbone structure sim-
ilar to that of ginsenoside Rg3. Interestingly, ginsenoside Rh2
inhibited [3H]BTX-B binding in rat brain membrane fractions
and attenuated glutamate release (Duan et al., 2006; Duan and
Nicholson, 2008), showing that the ginsenoside Rg3-induced
interaction with rat brain NaV1.2 channel activity may involve
the BTX binding sites, and that the interference by ginsenoside
of [3H]BTX-B binding in rat brain membrane fractions is rele-
vant to ginsenoside Rg3-induced Na+ channel regulation. BTX
interaction sites are located at the I433, N434, and L437 residues
of the NaV1.4 channel and equivalent residues such as I417,
N418, and L421 of brain NaV1.2 channels in domain-I segment
6 (IS6).
Channel mutations in BTX binding sites, such as N418K and
L421K in rat brain NaV1.2, and L437K in the mouse skeletal
muscle NaV1.4 channel, have been shown to attenuate or abol-
ish ginsenoside Rg3 inhibition of Na+ currents (Figure 2). In
addition, channel mutations in BTX binding sites also greatly
attenuate the ginsenoside Rg3-mediated depolarizing shift in the
activation voltage observed in wild-type channels. Moreover,
ginsenoside Rg3-mediated use-dependent inhibition was almost
abolished in these mutant channels. BTX binding sites in brain-
and muscle-type Na+ channels play important roles in gin-
senoside Rg3-mediated Na+ channel interaction at cellular and
molecular levels (Lee et al., 2008b).
GINSENOSIDE PHARMACOLOGY IN THE INTERACTION
WITH MEMBRANE RECEPTOR LIGAND-GATED ION
CHANNELS
REGULATION OF GABAA AND GLYCINE RECEPTOR CHANNEL ACTIVITY
BY GINSENOSIDES
Ginseng has been shown to have an anxiolytic-like effect in animal
model studies (Kim et al., 2009). Recent studies have shown that
ginsenosides interact with the GABAA receptor, and may regulate
the binding of the ligand with the GABAA receptor. Ginsenosides
differentially regulate the binding of [3H]-flunitrazepam or [3H]-
muscimol to the GABAA receptor in a rat brain membrane
fraction (Kimura et al., 1994). On the other hand, prolonged infu-
sion with ginsenoside Rc in the rat brain elevates [3H]-muscimol
binding to the GABAA receptor in a brain region-specific man-
ner, while ginsenoside Rg1 has no effect (Kim et al., 2001). Thus,
ginsenosides may regulate the GABAA receptor by affecting the
binding affinities of its ligands.
In a GABAA receptor channel activity study, ginsenosides
were also shown to regulate GABAA receptor channel activ-
ity by enhancing GABA-mediated channel activity (Choi et al.,
2003a). Thus, in studies using Xenopus oocytes expressing human
recombinant GABAA receptor, ginsenosides Rb1, Rb2, Rc, Rd,
Re, Rf, Rg1, and Rg2 affected GABAA receptor channel activity,
and ginsenoside Rc most potently enhanced the GABA-induced
inward peak current (IGABA). Bicuculline, a GABAA receptor
antagonist, and picrotoxin, a GABAA channel blocker, blocked
the stimulatory effect of ginsenoside Rc on IGABA. Niflumic acid
(NFA) and 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid, both
Cl− channel blockers, attenuated the effect of ginsenoside Rc on
GABA-induced inward peak current.
Compared to the GABAA receptor, few investigations have
been carried out into the ginsenoside-mediated action on glycine
receptor channel activity. In a study using human glycine α1
receptor channel expressed in Xenopus oocytes, Noh et al.
(2003) demonstrated that although treatment with ginsenoside
Rf enhanced the glycine-induced inward peak current in a dose-
dependent and reversible manner, ginsenoside Rf itself did not
elicit membrane currents. The effect of ginsenoside Rf action
on glycine receptor channel activity was blocked by strychnine,
a glycine receptor antagonist, and 4,4′-disothiocyanostilbene-
2,2′-disulfonic acid (DIDS), a Cl−channel blocker. The various
ginsenosides, listed in order of potency for the enhancement
of the glycine-induced inward Cl− current, were ginsenoside
Rb1 > >Rb2 > Rg2 = Rc > Rf > Rg1 > Re. Further study will
be helpful for elucidation of the interaction of ginsenosides with
glycine receptor proteins to enhance the glycine-induced inward
Cl− current.
GINSENOSIDE Rg3 INTERACTS WITH THE γ2 SUBUNIT TO REGULATE
GABAA RECEPTOR CHANNEL ACTIVITY
Two characteristics of ginsenoside Rg3-induced GABAA recep-
tor interaction have been described. First, ginsenoside Rg3 itself
evoked an inward current in a concentration-dependent man-
ner in Xenopus oocytes expressing human recombinant GABAA
receptor (α1β1γ2S) in the absence of GABA. Ginsenoside Rg3-
elicited inward currents were blocked by a GABAA receptor
antagonist, indicating that ginsenoside Rg3 itself activates GABAA
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receptors (Lee et al., 2013b). Ginsenoside Rg3-elicited inward
currents were not observed in the absence of the γ2S or γ2L
subunits. The magnitude of the ginsenoside Rg3-elicited inward
current was dependent on the expression ratio of the γ2S subunit.
However, ginsenoside Rg3 exerted no effects in oocytes expressing
other subunits, such as γ1, γ3, δ, and ε, with α1β1.
The γ2 subunit of the GABAA receptor plays an important
role in the action of human epilepsy (Bowser et al., 2002).
The γ2 subunit of the GABAA receptor is also essential for
the formation of high-affinity benzodiazepine-binding sites, and
mutations in benzodiazepine-binding sites greatly attenuated
the benzodiazepine-induced potentiation of IGABA (Buhr et al.,
1997). In addition, increased expression of the γ2 subunit com-
pared to other subunits further potentiated benzodiazepine-
induced IGABA (Boileau et al., 2003). However, GABAA receptors
with mutant γ2 subunit benzodiazepine-binding sites did not
affect the action of ginsenoside Rg3 (Lee et al., 2013b). Thus,
it is unlikely that the ginsenoside Rg3-induced activation of
α1β1γ2 GABA receptors is achieved through interaction with
benzodiazepine-binding sites.
Second, co-treatment of ginsenoside Rg3 with GABA fur-
ther potentiated IGABA in oocytes expressing GABAA receptor
(α1β1γ2S) (Lee et al., 2013b). However, the potentiating effect
of ginsenoside Rg3 on IGABA was not specific to the γ2 sub-
unit, and co-expression of other subunits such as γ1, γ3, δ, and
ε also enhanced IGABA. The degree of potentiation of IGABA by
ginsenoside Rg3 was not significantly different in the presence
of different subunits. Even ginsenoside Rg3 enhanced IGABA in
oocytes expressing α1β1 subunits and ginsenoside Rg3 itself did
not elicit inward currents in oocytes expressing α1β1 GABAA
receptor in the absence of GABA. Thus, ginsenoside Rg3 may
have dual binding sites for GABAA receptor modifications, one
for GABA binding sites in the presence of GABA and the other
one for γ2 subunit in the absence of GABA. However, ginsenoside
Rg3 had no effects on GABAc receptor channel activity (Lee et al.,
2013b).
REGULATION OF 5-HT3 RECEPTOR CHANNEL ACTIVITY BY
GINSENOSIDES
Ginsenoside Rg2 and ginsenoside metabolites inhibit 5-HT3
receptor-mediated ion currents (I5−HT) in Xenopus oocytes
expressing 5-HT3 receptors (Choi et al., 2003b; Lee et al., 2004a).
The inhibitory effect of ginsenoside Rg2 on 5-HT-induced inward
currents was non-competitive and voltage-independent, similar
to the ginsenoside-induced modulation of heteromeric nicotinic
acetylcholine receptor. In addition, the inhibitory effect of gin-
senoside Rg3 on serotonin-induced currents (I5−HT) is observed
when applied extracellularly but not intracellularly (Lee et al.,
2004b), indicating that ginsenoside Rg3 regulates 5-HT3 receptors
outside the cell.
GINSENOSIDE Rg3 REGULATES 5-HT3 RECEPTOR CHANNEL ACTIVITY
THROUGH INTERACTIONWITH AMINO ACIDS AT THE CHANNEL
GATING REGION
Mutations in V291A, F292A, and I295A in the transmembrane
domain 2 (TM2) greatly attenuated or abolished ginsenoside Rg3-
induced inhibition of peak I5−HT . Thus, ginsenoside Rg3 acts
through the 5-HT3 receptor protein, and alterations in TM2 of
the 5-HT3 receptor could affect the action of ginsenoside Rg3
(Lee et al., 2007). Interestingly, the V291A mutation, although
not the F292A or I295A mutations, induced constitutively active
ion currents, with a decreased current decay rate. Ginsenoside
Rg3 treatment of this mutant receptor accelerated the rate of cur-
rent decay in the presence of 5-HT, suggesting that the presence
of ginsenoside Rg3 caused channel closure rather than opening.
Thus, ginsenoside Rg3 and TMB-8, an open channel blocker,
inhibited the constitutively active ion currents. Diltiazem, another
open channel blocker, did not prevent ginsenoside Rg3-induced
inhibition of the constitutively active ion currents in occlusion
experiments (Lee et al., 2007). This report provides the following
insight: first, ginsenoside Rg3 inhibits 5-HT3A receptor chan-
nel activity through interaction with residues V291, F292, and
I295 in the channel gating region of TM2, and second, ginseno-
side Rg3 regulates 5-HT3A receptor channel activity in the open
state at different site(s) from those used by TMB-8 and dilti-
azem. Thus, ginsenoside Rg3 inhibits the 5-HT3 receptor in the
open state through interactions with V291, F292, and I295. The
identification of ginsenoside Rg3 interacting sites in the 5-HT3
receptor indicates that ginsenoside Rg3 achieves its pharmaco-
logical actions via a specific interaction with the 5-HT3 receptor
(Figure 4).
REGULATION OF NICOTINIC ACETYLCHOLINE RECEPTOR CHANNEL
ACTIVITY BY GINSENOSIDES
Ginsenosides inhibit acetylcholine-stimulated catecholamine
release from chromaffin cells, which mainly contain α3β4 nico-
tinic acetylcholine receptors involved in catecholamine release
FIGURE 4 | Topology and sequence alignment of α7 nicotinic
acetylcholine (nACh) and 5-HT3A receptors at transmembrane domain
2 (TM2). α7nACh and 5-HT3A receptors consist homomeric pentamer. TM2
of each segment forms a channel pore. The underlined specific amino acid
residues in those ligand-gated channels are thought to interact with
20(S)-ginsenoside Rg3 (Lee et al., 2007, 2009).
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(Tachikawa et al., 2001). Furthermore, ginsenosides also inhib-
ited acetylcholine-induced inward currents in oocytes express-
ing nicotinic receptor α1β1δε or α3β4 subunits, suggesting that
ginsenosides directly regulate nicotinic acetylcholine receptor
channel activities (Choi et al., 2002). However, ginsenosides
themselves had no effect on basal currents in oocytes express-
ing nicotinic acetylcholine receptor αβδε or α3β4 subunits. The
inhibition of acetylcholine-induced inward currents by ginseno-
sides in oocytes expressing nicotinic acetylcholine receptor αβδε
or α3β4 subunits was reversible, voltage-independent, and non-
competitive, indicating that ginsenosides may bind to the nico-
tinic acetylcholine receptor when channels are open, but do not
compete with acetylcholine to regulate these receptors (Choi
et al., 2002). Interestingly, it appears that protopanaxatriol gin-
senosides such as Re, Rf, Rg1, or Rg2 were more potent than
protopanaxadiol ginsenosides such as Rb1, Rb2, Rc, and Rd in
inhibiting acetylcholine-induced inward currents (Choi et al.,
2002). On the other hand, ginsenoside Rg2 reduced the peak cur-
rent and increased the desensitization of acetylcholine-induced
inward currents in oocytes expressing human neuronal nico-
tinic acetylcholine receptors such as α3β4, α3β2, α4β4, and α4β2
(Sala et al., 2002). Thus, the inhibitory effects of ginsenosides
on acetylcholine-stimulated attenuation of catecholamine release
are achieved through nicotinic acetylcholine receptor channel
activity.
In Xenopus oocytes heterologously expressing the α9α10 nico-
tinic acetylcholine receptor, ginsenosides blocked acetylcholine-
induced inward currents (IACh), listed in order of potency, with
ginsenoside Rg3 > Rb2 > CK > Re = Rg2 > Rf > Rc > Rb1 >
Rg1 in a reversible manner, and the blocking effect of ginseno-
side Rg3 on IACh was the same after pre-application compared to
co-application of ginsenoside Rg3. Ginsenoside Rg3-induced IACh
inhibition was not affected by acetylcholine concentration and
was independent of membrane holding potential. The inhibitory
effect of ginsenoside Rg3 on IACh was not observed in oocytes
expressing the α9 subunit alone, indicating that the presence of
the α10 subunit is required for ginsenoside Rg3-induced regu-
lation of α9α10 nicotinic acetylcholine receptor channel activity
(Lee et al., 2013a). The α10 subunit of the α9α10 nicotinic
acetylcholine receptor may play an important role in ginsenoside
Rg3-induced interaction with the α9α10 nicotinic acetylcholine
receptor.
IDENTIFICATION OF GINSENOSIDE INTERACTION SITES IN THE
REGULATION OF THE NICOTINIC ACETYLCHOLINE RECEPTOR
In contrast to heteromeric acetylcholine receptors, ginsenosides
had no effect on wild-type homomeric α7 nicotinic acetylcholine
receptor-mediated ion currents (Lee et al., 2009). The homomeric
α7 nicotinic acetylcholine receptors, which are predominantly
expressed in the cortical and limbic areas, are the major bind-
ing sites for α-bungarotoxin in the mammalian central nervous
system and are Ca2+ permeable (Gotti et al., 2009). The α7
nicotinic acetylcholine receptor and the 5-HT3A receptors are
both homomeric ligand-gated ion channels. Interestingly, single
point mutations of Leu247 to Thr247 in the highly conserved
TM2, which forms the channel pore region, creates gain-of-
function alterations, including slower desensitization, increased
acetylcholine affinity, and a linear current-voltage relationship,
as well as altering pharmacological properties such as the con-
version of various α7 nicotinic acetylcholine receptor antagonists
into agonists (Revah et al., 1991; Bertrand et al., 1992). Thus, the
L247 residue of the α7 nicotinic acetylcholine receptor could be a
useful target for drug development and a focal point in the inves-
tigation of channel gating of the acetylcholine receptor (Palma
et al., 2006). In addition, the Leu residue corresponding to posi-
tion 247 of the chick α7 nicotinic acetylcholine receptor channel
is highly conserved in all nicotinic, GABAA, 5-HT3, and glycine
receptors, and is believed to be positioned at the gate (Lester et al.,
2004). Moreover, recently acquired high resolution structures of
the nicotinic acetylcholine receptor channel show that the con-
served Leu is located at the narrowest part of the channel, and that
the side chain of the amino acid head points toward the lumen
of the pore (Miyazawa et al., 2003). The importance of position
247 for gating and conductance has also been demonstrated in a
functional study (Bertrand et al., 1992).
The mutation of Leu247 to various other amino acid residues
induces changes in the receptor sensitivity to ginsenoside Rg3.
Interestingly, mutations in L247 to L247A, L247D, L247E, L247I,
L247S, and L247T, although not L247K, rendered mutant recep-
tors sensitive to ginsenoside Rg3 (Lee et al., 2009). Ginsenoside
Rg3 inhibition of the mutant α7 nicotinic acetylcholine recep-
tor channel currents was reversible and concentration-dependent.
In addition, ginsenoside Rg3 inhibition of the mutant α7 nico-
tinic acetylcholine receptor was strongly voltage-dependent and
non-competitive. The homology docking model between gin-
senoside Rg3 and the mutant receptor revealed that ginseno-
side Rg3 forms hydrogen bonds with amino acids, such as
Ser240 of subunit I and Thr244 of subunits II and V at
the channel pore, whereas the wild-type receptor ginseno-
side Rg3 localizes at the interface of the two wild-type recep-
tor subunits. Thus, the mutation of Leu247 to Thr247 may
induce conformational changes in the wild-type receptor, cre-
ating a binding pocket for ginsenoside Rg3 at the channel pore
(Figure 4).
REGULATION OF N-METHYL-D-ASPARTATE (NMDA) RECEPTOR
CHANNEL ACTIVITY BY GINSENOSIDES
Ginsenosides Rb1 and Rg3 have been shown to attenuate
glutamate- and NMDA-induced neurotoxicity by inhibiting the
overproduction of nitric oxide, the formation of malondialde-
hyde, and the influx of Ca2+ in rat cortical cultures (Kim
et al., 1998b). In addition, in rat hippocampal cultures, gin-
senosides and ginsenoside Rg3 attenuated high K+-, glutamate-,
and NMDA-induced Ca2+ influx (Kim et al., 2002). Seong et al.
(1995) showed that ginsenosides attenuated glutamate-induced
swelling of cultured rat astrocytes. Notoginsenoside R1 prevents
glutamate-mediated neurotoxicity in cultured mouse cortical
neurons (Gu et al., 2009). On the other hand, in an in vivo
study using anesthetized rats, intracerebroventricular adminis-
tration of ginsenoside Rb1, and not Rg1,significantly inhibited
the magnitude of long term potentiation induced by strong
tetanus in the dentate gyrus, although ginsenoside Rb1 did not
affect the basal synaptic responses evoked by low-frequency
tests (Abe et al., 1994). Pretreatment with ginsenosides via the
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intrathecal route attenuated NMDA- or substance P-induced
nociceptive behavior, but had no effect on glutamate-induced
behavior (Yoon et al., 1998; Shin et al., 1999). Pretreatment of
ginsenosides via the intraperitoneal route also attenuated cell
death of hippocampal neurons induced by kainate (Lee et al.,
2002). Ginsenosides Rh2 and Rg3 inhibit NMDA receptor chan-
nel currents in cultured rat hippocampal neurons (Lee et al.,
2006a). Regarding the effects of ginsenoside metabolites such as
compound K (CK), protopanaxadiol (PPD), and protopanaxa-
triol (PPT) on NMDA receptor channel activity, PPT, unlike CK
and PPD, reversibly inhibited NMDA-mediated inward currents
(INMDA) in a concentration-dependent manner. PPT inhibition
of INMDA was non-competitive with NMDA, and was indepen-
dent of the membrane holding potential (Shin et al., 2012), even
though ginsenoside Rh2, Rg3, and PPT interact with the NMDA
receptor.
IDENTIFICATION OF GINSENOSIDE INTERACTION SITES IN THE
REGULATION OF THE NMDA RECEPTOR
Ginsenoside Rg3 does not compete with NMDA in NMDA
receptor-mediated ion current inhibition in rat hippocam-
pal neuron cultures (Kim et al., 2004b; Lee et al., 2006a).
In addition, ginsenoside Rg3 does not interact with Mg2+
or phencyclidine (PCP, MK-801, ketamine) binding sites.
However, the inhibitory effect of ginsenoside Rg3 on NMDA
receptor-mediated ion currents was attenuated by increas-
ing glycine concentrations, whereas ginsenoside Rh2-mediated
inhibition of NMDA receptor-mediated ion currents were atten-
uated by increasing spermine concentrations. Thus, ginseno-
side Rg3 and ginsenoside Rh2 selectively targeted NMDA
receptors with different NMDA receptor regulatory sites (Lee
et al., 2006a). These reports show the possibility that gin-
senoside Rg3 is a competitive antagonist at the glycine- and
polyamine-binding site, although the specific amino acid(s)
involved in ginsenoside Rg3 binding have not been identi-
fied. Site-directed mutagenesis may provide further information
about the interaction of ginsenoside Rg3 with glycine binding
site(s).
CHACTERIZATIONS OF GINSENOSIDE Rg3-MEDIATED
ACTONS ON ION CHANNELS AND RECEPTORS
Ginsenosides exhibit several principles in their actions of a vari-
ety of ion channels and receptors. Firstly, ginsenosides do not
affect most of ion channel and receptor activities, when they are at
rest or without ligand stimulations (Nah et al., 2007). But, when
voltage-gated ion channels are depolarized or receptors are acti-
vated by the relevant receptor agonists, ginsenosides affect ion
channel or ligand-gated ion channel activities. Thus, conforma-
tional changes to ion channels or receptor proteins induced by
depolarization or receptor ligand binding may provide an oppor-
tunity for ginsenoside Rg3 to bind ion channels or receptors to
exert its action (i.e., Na+ channels and 5-HT3 receptor) (Lee et al.,
2007, 2008c).
Secondly, in ginsenoside Rg3-induced voltage-gated ion chan-
nel regulations, the ginsenoside Rg3 effects on voltage-gated
Ca2+, K+, and Na+ channel currents were achieved via inter-
action with transmembrane domain-I-segment 6, which is
known to form a channel pore or pore entryway. Ginsenoside
Rg3-induced inhibition of L-type Ca2+ channel currents was
attenuated by mutations of Leu427, Asn428, and Leu431 in trans-
membrane domain-I-segment 6 residues (Choi et al., 2009).
Similarly, N418K and L421K mutant rat brain NaV1.2, and
L437K mutant mouse skeletal muscle NaV1.4 channel attenu-
ated or abolished ginsenoside Rg3 inhibition of Na+ currents.
Another interesting observation was the consistent pattern exhib-
ited in ginsenoside Rg3-mediated action on various K+ channel
subtypes. As shown in Figure 3, K+ channels have a common
feature, in that they all have a pore-lining P-loop with a con-
sensus amino acid sequence –TXGYGD–, which is called the
K+ channel “signature sequence” (Heginbotham et al., 1994).
These residues, repeated in each of the 4 α subunits, form the
K+ selectivity filter. Ginsenoside Rg3-mediated human Kv1.4,
KCNQ (IKs), hERG, and BKCa K+ channels are regulated through
interaction with K531 and K318, V319, S631, and Y360 residues
respectively, all of which are the first or second amino acid
after –TXGYGD–. They are all located at the channel pore entry
(Lee et al., 2008a; Choi et al., 2010, 2011a,b) (Figure 2). Thus,
ginsenoside Rg3 has a common interaction site near the “sig-
nature sequence” in the subsets of the K+ channels examined.
However, the interaction of ginsenoside Rg3 with these K+ chan-
nel subtypes exhibits differential effects (i.e., activation of BKCa,
IKr , IKs or inhibition of Kv1.2 and Kv4.2). Another important
characteristic in Kv1.4 and BKCa channel interaction with gin-
senoside Rg3 is the sharing of other K+ channel regulator bind-
ing sites such as the extracellular TEA binding site, although
TEA structure is different from that of ginsenoside (Lee et al.,
2008a).
Thirdly, ginsenoside Rg3 exhibits its effects via differential
interactions with ligand-gated ion channels. Ginsenoside Rg3-
induced actions of 5-HT3 and mutant α7 nicotinic acetylcholine
receptor are achieved via interaction with amino acids in TM2,
which forms channel pore (Choi et al., 2009). Ginsenoside
Rg3 regulates GABAA receptor channel activity via γ2 subunit,
whereas ginsenoside Rg3 regulate NMDA receptor channel activ-
ity via allosteric interaction sites such as co-agonist, glycine or
polyamines, binding site.
Finally, there might be a compensatory action by ginseno-
side action in ion channel regulations. For example, ginseno-
side Rg3 stabilizes membrane potentials through the inhibition
of both Ca2+ and Na+ channels, but ginsenoside Rg3 might
induce a depolarization of neuronal cells by inhibiting Kv1.4 and
Kv4.2 channel activity. Thus, ginsenoside Rg3 action is interest-
ing because the same inhibitory effects on Ca2+, Kv1.4 and Kv4.2,
and Na+ channels could result in opposite effects in neurons. One
possible speculation on the actions of ginsenoside Rg3 on nervous
system is that suppression of neuronal excitability by ginsenoside
Rg3-mediated Ca2+ and Na+ channel inhibition could be to some
extent compensated by inhibition of Kv1.4 and Kv4.2 channel
activity. On the other hand, there is no evidence that ginsenoside
directly binds to ion channels or receptors, since most of stud-
ies are indirectly obtained from mutation experiments. In future
studies, it will be needed to obtain direct evidence(s) to confirm
ginsenoside binding to ion channel or ligand-gated ion channel
proteins.
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A LINKAGE OF THE GINSENOSIDE-MEDIATED ION
CHANNELS AND RECEPTOR INTERACTIONS BETWEEN
GINSENG PHARMACOLOGY
In traditional medicine, ginseng was utilized as a tonic to
invigorate body (Nah et al., 2007). Ginsenoside-mediated
actions of ion channels and receptors could underlie molec-
ular bases for the explanations of traditional ginseng phar-
macology. Here, this review illustrates representative examples
how ginsenoside-mediated actions of ion channels and recep-
tors link to ginseng pharmacology. In normal Ca2+ homeostatic
state, cytosolic calcium plays a key role for learning, mem-
ory and other many cellular events (Berridge et al., 1998). In
contrast, Ca2+ dyshomeostasis is one of important events in
brain ischemic and traumatic brain injury (Wojda et al., 2008).
Ginsenoside might be helpful for neuroprotection by negative
coupling of [Ca2+]i in Ca2+ dyshomeostasis of nervous systems.
FIGURE 5 | A schematic illustration on cytosolic Ca2+ overload
signalings and ginsenoside-mediated attenuation against cytosolic Ca2+
overload. This schematic drawing shows that cytosolic Ca2+ levels could be
elevated in ischemic or traumatic brain injury. The elevation of cytosolic Ca2+
levels occurs either via direct activation of voltage-gated Ca2+ channels or via
depolarization caused by voltage-dependent Na+ channel activation and other
excitatory ligand-gated ion channels at pre- and post-synaptic sites. The
overload of cytosolic Ca2+ levels caused by excitatory neurotransmitters or
neurotoxins may initiate the persistent activation of Ca2+-dependent
signaling, resulting in damage, for instance through apoptosis or necrosis.
Although ginsenoside has no effects on ion channels and ligand-gated ion
channels at rest state of neurons, ginsenoside might exhibit its effects by
attenuation of cytosolic Ca2+ elevation by abnormal conditions by inhibiting
ion channels and receptors (as indicated with “x” in arrow). The detailed
explanations were described in text. Ginsenoside exhibits differential
regulations on subsets of K+ channels. So, one possible hypothesis is that
K+ channels regulated by ginsenoside might play a balancing role on Ca2+
and Na+ channel inhibitions by ginsenoside.
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Brain injury will cause ATP exhaustion by mitochondrial dys-
function and also subsequently couples to the slow secondary
excitotoxicity by glutamate (Pang and Geddes, 1997). The sec-
ondary glutamate-induced excitotoxicity in ATP deficient neu-
rons is initiated by voltage-dependent Na+ channel activation,
which is coupled tomembrane depolarization, Ca2+ channel acti-
vation, and subsequent NMDA receptor activation (Alzheimer,
2002). Moreover, pathologically elevated Na+ and Ca2+ levels
in the cytosol are likely to trigger a cascade of molecular events
that eventually lead to neuronal death (e.g., formation of reactive
oxygen species, lipid peroxidation, mitochondrial dysfunction,
activation of calpain and caspases, etc.). As described above,
ginsenosides inhibit cytosolic Ca2+ and Na+ elevation through
these channel activations as well as NMDA receptor inhibition
(Lee et al., 2006a). Thus, negative couplings of ginsenosides to
Ca2+ and Na+ channels and NMDA receptors might be help-
ful for the attenuation of excitotoxity under the brain ischemic
and traumatic brain injury. Figure 5 illustrate a schematic exam-
ple based on reports how ginsenoside-mediated interactions
with Ca2+ and Na+ channels and NMDA receptors may be
coupled to neuroprotective effects against Ca2+ dyshomeosta-
sis induced by uncontrolled Ca2+ and Na+ channels or NMDA
receptors (Lee et al., 2002, 2006a; Kim and Rhim, 2004; Park
et al., 2004; Kim et al., 2005c; Lian et al., 2005; Tian et al.,
2005; Kim et al., 2007, 2008b; Zhang et al., 2008; Cheon et al.,
2013).
Table 1 | Summary of EC50 or IC50 on ginsenoside-induced inhibition or stimulation of various voltage-gated ion or ligand-gated ion channel
activities.
Voltage-gated ion channels Ginsenoside (Effect) EC50 or IC50 (μM) Interaction sites References
Ca2+ CHANNELS IN CULTURED CELLS
Sensory neurons Rf (Inhibition) 40 Nah et al., 1995
Chromaffin cells GTS (Inhibition) ND Choi et al., 2001
Sensory neurons GTS and Rg3 (Inhibition) ND Rhim et al., 2002
Hippocampal neurons Rb1 (Inhibition) ND Lin et al., 2012
Cardiomyocytes Re (Inhibition) ND Bai et al., 2004
Ca2+ CHANNEL SUBTYPES EXPRESSED IN XENOPUS OOCYTES
L Rg3 (Inhibition) 39.9±9.5 L417, N428, L431 Lee et al., 2006b
N Rg3 (Inhibition) 64.4±13.6 Lee et al., 2006b
P/Q Rg3 (Inhibition) 29.6±11.3 Lee et al., 2006b
R Rg3 (Inhibition) 57.5±12.5 Lee et al., 2006b
T Rg3 (Inhibition) 97.3±12.4 Lee et al., 2006b
K+ CHANNELS IN CULTURED CELLS
KCa in vascular smooth muscle GTS (Activation) ND Li et al., 2001
IKs in cardiomyocytes Re (Activation) 1.4±0.4 Furukawa et al., 2006
K+ CHANNELS EXPRESSED IN XENOPUS OOCYTES
Kv1.4 Rg3 (Inhibition) 32.6±2.2 K531 Lee et al., 2008a
BKCa Rg3 (Activation) 15.3±3.1 Y360 Choi et al., 2011a
hERG (IKr ) Rg3 (Activation) 0.41±0.05 S631 Choi et al., 2011b
KCNQ (IKs) Rg3 (Activation) 15.2±8.7 K318, V318 Choi et al., 2010
Na+ CHANNELS EXPRESSED IN tsA201 CELLS
Brain2a Na+ channel GTS (Inhibition) ND Liu et al., 2001
Na+ CHANNELS EXPRESSED IN XENOPUS OOCYTES
Nav1.2 Rg3 (Inhibition) 32.0±6.0 I417, N418, L421 Lee et al., 2008b
Nav1.4 Rg3 (Inhibition) 58.5±6.3 I433, N434, L437 Lee et al., 2008b
Nav1.5 Rg3 (Inhibition) 16.1±2.8 Kang et al., 2005
LIGAND-GATED ION CHANNELS EXPRESSED IN XENOPUS OOCYTES
GABAA Rc (Activation) 53.0±12.3 Choi et al., 2003a,b
Glycine Rf (Activation) 49.8±9.8 Noh et al., 2003
5-HT3 Rg3 (Inhibition) 27.6±4.3 V291, F292, I295 Lee et al., 2007
Nicotinic acetylcholine
α3β4 Rg2 (Inhibition) 60±14 Choi et al., 2002
α1β1δε Rg2 (Inhibition) 16±9 Choi et al., 2002
α7 (L247A mutant) Rg3 (Inhibition) 33.1±1.3 L247 Lee et al., 2009
NMDA Protopanaxatriol (Inhibition) 48.1±16 Shin et al., 2012
EC50 (BKCa, hERG, and KCNQ (IKs) K+ channels, and GABAA and glycine receptors) or IC50 (the remainder) values were determined in oocytes expressing the
specified ion channels or receptors. GTS, ginseng total saponin fraction; ND, not determined.
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Ginseng and ginsenosides have also been reported to alleviate
stress-induced symptoms and lesions (Attele et al., 1999). Stress is
one ofmain causes for development of almost all types of diseases.
The adrenal gland is one of the peripheral organs responding to
stress. In stress situation, the adrenal gland secrets catecholamines
from the medulla and renders the organs to cope with stress.
α3β4 nicotinic acetylcholine receptors in adrenal medulla play
a key role in catecholamine secretion. Ginsenosides and their
metabolites inhibit α3β4 nicotinic acetylcholine receptor channel
activity and catecholamine release (Tachikawa et al., 2001; Choi
et al., 2002). Thus, ginsenosides might be helpful for alleviation
of stress by controlling catecholamine secretion during over-stress
situation.
On the other hand, traditional medicine also showed that
ginseng is utilized for the alleviation of emesis, which includes
nausea and vomiting. Nausea and vomiting are significant adverse
effects of anti-cancer agents such as cisplatin, and cause signifi-
cant patient morbidity. 5-HT3 receptors are involved in vomiting
and irritable bowel syndrome (Kim et al., 2005a,b). Ginsenoside-
mediated action of 5-HT3A receptor channel activity may be
the molecular basis of the anti-vomiting action of ginseng.
Ginsenoside might be used for attenuation of anticancer agent-
induced side effects of vomiting and nausea.
There are multiple cardiovascular effects attributed to ginseng,
including cardioprotection, antihypertensive effects, and attenu-
ation of myocardial hypertrophy, heart failure, and the ischemic
and reperfused heart in a variety of experimental models (Attele
et al., 1999). Ginseng total saponins and ginsenoside Rg3 regu-
late L-type Ca2+ and various K+ channel activities. Especially,
ginsenoside Re enhances IKr and IKs channel currents in guinea
myocytes (Bai et al., 2003, 2004). Ginsenoside Rg3 also delays
deactivation of IKs and enhances IKr . In heart, IKr and IKs chan-
nels are clinically important and are target for drug development,
since dysfunction of these channels is associated with sudden
death in human (Bai et al., 2004). Thus, ginsenosides-mediated
actions of IKr and IKs channels as well as K+ channels might
contribute to cardioprotective effects of ginseng.
SUMMARY
The pharmacological behaviors of ginseng are diverse rather than
unique, since ginsenosides, as one of active ingredients of gin-
seng, exhibit differential pharmacological actions in ion channels
or ligand-gated ion channel regulations. Therefore, it is unlikely
that ginseng ginsenoside achieves its diverse effects on ion chan-
nels and receptors via mediation of its own receptor activations
on plasma membrane for the following reasons. Firstly, ginseno-
side affinity for ion channels and receptors is very low compared
to other receptor-specific ligands or toxins (Table 1). Rather, gin-
senosides directly interact with various ion channel proteins and
receptors without selectivity (Table 1). Secondly, since ginseno-
side does not have its receptor on plasma membrane, ginsenoside
does not induce spontaneous cellular responses in ion channel or
receptor activity without stimuli such as depolarization or recep-
tor ligands. Thus, diverse actions of ginsenoside on ion channels
and receptors without its specific receptor mediations could be
a limitation on its therapeutic use. Nevertheless, since ginseng
influences various body functions as a traditional medicine, a
pharmacological role of ginsenosides through the interactions
with diverse ion channels and receptors might have potential as a
prevention or treatment for a variety of nervous system disorders.
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